Landau, MA
Bernard R. Landau, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20090163442 | TREATMENT OF CANCER WITH 2-DEOXYGALACTOSE - 2-Deoxygalactose and its analogs can be used to treat cancer and to improve patient outcome when administered in therapeutically effective doses alone or in combination with other anti-cancer drugs or with surgical resection or radiation therapy. | 06-25-2009 |
Herbert Landau, Bedford, MA US
Patent application number | Description | Published |
---|---|---|
20090276183 | ASSOCIATING OBSERVATIONS IN A MULTI-SENSOR SYSTEM USING AN ADAPTIVE GATE VALUE - In one aspect, a method to assign observations includes receiving first observations of a first sensor system, receiving second observations of a second sensor system and assigning a set of pairs of the first and second observations predicted to correspond to the same physical position. The assigning includes using a likelihood function that specifies a likelihood for each assigned pair. The likelihood is dependent on the assignment of any other assigned pairs in the set of assigned pairs. The assigning also includes determining the set of assigned pairs for the first and second observations based on the likelihood function. The likelihood function uses a gate value determined from estimating a true volume using nearest neighbor distances determined from the first and second observations. | 11-05-2009 |
20100070238 | Multiple sensor fusion engine - A method and system for of fusing the outputs of multiple sensors. The output of each sensor including a sensor class probability vector based on each sensor's classification database is input to a fusion engine which estimates a base class probability vector based on the sensor class probabilities output by the sensors and a preconfigured base database including base classes. | 03-18-2010 |
Matthew Landau, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20140372256 | CONTEXT DEPENDENT DATA MANAGEMENT AND DISPLAY - A system receives a request for item data from a stored data set. The request may include a specified context for providing the item data. The stored data set includes an item, at least one common item attribute, a value for each of the common item attributes, and at least one context item attribute. The system provides the requested item data. The provided item data includes context attribute values for the specified context and common attribute values for attributes that are not in the specified context attributes. | 12-18-2014 |
Matthew J. Landau, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20080270398 | Product affinity engine and method - The present invention relates to a computerized engine and method for using the same to determine and effect product sales to customers based on customer-driven affinities relating to the products. In some embodiments, the computerized engine includes hardware and software and uses customer or transaction data or product characteristics to calculate an output relating to the affinity. In some embodiments, the computerized engine provides an output indicative of the affinity. In some embodiments, the computerized engine is coupled to a database containing the customer or transaction data or product characteristics. The system and method can also determine a reduced affinity depending on a period of time elapsed between a pair of events being related, or as a function of the age of collected affinity data. | 10-30-2008 |
Steven Landau, Wellesley, MA US
Patent application number | Description | Published |
---|---|---|
20090163442 | TREATMENT OF CANCER WITH 2-DEOXYGALACTOSE - 2-Deoxygalactose and its analogs can be used to treat cancer and to improve patient outcome when administered in therapeutically effective doses alone or in combination with other anti-cancer drugs or with surgical resection or radiation therapy. | 06-25-2009 |
Steven B. Landau, Wellsley, MA US
Steven B. Landau, Wellesley, MA US
Patent application number | Description | Published |
---|---|---|
20080269276 | COMPOSITIONS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME - The present invention relates to a method of treating irritable bowel syndrome with constipation (IBS-c) or irritable bowel syndrome with alternating constipation and diarrhea (IBS-a) in a subject in need of treatment. The method comprises administering to said subject a therapeutically effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof. | 10-30-2008 |
20090048287 | Compositions useful for treating gastrointestinal motility disorders - The present invention relates to method of treating a gastrointestinal motility disorder in a subject in need of treatment comprising coadministering to said subject a first amount of a compound having 5-HT | 02-19-2009 |
20090131471 | Compositions useful for treating gastroesophageal reflux disease - The present invention relates to a method of treating GERD in a human subject in need of treatment. The method comprises orally administering to said subject an effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof, wherein the effective amount is from about one to about three daily doses of the compound and the dose is from about 0.2 mg to about 0.5 mg. | 05-21-2009 |
20100152231 | Compositions Useful For Treating Irritable Bowel Syndrome - The present invention relates to a method of treating irritable bowel syndrome with constipation (IBS-c) or irritable bowel syndrome with alternating constipation and diarrhea (IBS-a) in a subject in need of treatment. The method comprises administering to said subject a therapeutically effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof. | 06-17-2010 |
20100247584 | COMPOSITIONS USEFUL FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE - The present invention relates to a method of treating GERD in a human subject in need of treatment. The method comprises orally administering to said subject an effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof, wherein the effective amount is from about one to about three daily doses of the compound and the dose is from about 0.2 mg to about 0.5 mg. | 09-30-2010 |
20110269792 | COMPOSITIONS USEFUL FOR TREATING IRRITABLE BOWEL SYNDROME - The present invention relates to a method of treating irritable bowel syndrome with constipation (IBS-c) or irritable bowel syndrome with alternating constipation and diarrhea (IBS-a) in a subject in need of treatment. The method comprises administering to said subject a therapeutically effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof. | 11-03-2011 |
20110275667 | COMPOSITIONS USEFUL FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE - The present invention relates to a method of treating GERD in a human subject in need of treatment. The method comprises orally administering to said subject an effective amount of a thieno[3,2-b]pyridine compound of Structural Formula I or a pharmaceutically acceptable salt or N-oxide derivative thereof, wherein the effective amount is from about one to about three daily doses of the compound and the dose is from about 0.2 mg to about 0.5 mg. | 11-10-2011 |